+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Computer-aided Drug Discovery Market - Global Forecast 2025-2030- Product Image
Computer-aided Drug Discovery Market - Global Forecast 2025-2030- Product Image
Sale

Computer-aided Drug Discovery Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967979
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Computer-aided drug discovery is reshaping the pharmaceutical R&D landscape by embedding advanced computational approaches into every phase of therapeutic development. Senior executives are seeking solutions that reduce risk, accelerate time-to-market, and unlock new pathways for innovation. Staying ahead means understanding market dynamics, technology adoption, and competitive movements in this rapidly advancing field.

Market Snapshot: Computer-Aided Drug Discovery Market Growth Trajectory

The Computer-aided Drug Discovery Market grew from USD 4.08 billion in 2024 to USD 4.49 billion in 2025. It is expected to continue growing at a CAGR of 9.80%, reaching USD 7.16 billion by 2030. This momentum reflects broad adoption across both established pharmaceutical manufacturers and emerging biotech firms, with computational models increasingly supplementing and streamlining traditional research pipelines.

Scope & Segmentation of the Computer-Aided Drug Discovery Market

This report provides in-depth coverage of the sector, examining a wide array of modalities, delivery models, and end users to present a comprehensive market landscape.

  • Molecule Type: Biologics, Small Molecules
  • Deployment Model: Cloud-Based, On-Premises
  • Pricing Model: Pay Per Use, Perpetual License, Subscription
  • End User: Academic and Government Institutes, Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies
  • Type: Services (Consulting, Implementation, Research Outsourcing, Support and Maintenance), Software (Data Analytics, De Novo Design, Molecular Modeling, QSAR Modeling, Virtual Screening)
  • Technology: ADMET Prediction, Bioinformatics (Functional Genomics, Sequence Analysis), Chemoinformatics (Library Design, QSAR Modeling, Scaffold Hopping), De Novo Design, Molecular Modeling
  • Application: Clinical Trials Support, Lead Discovery, Lead Optimization, Preclinical Development, Target Identification
  • Geographies Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, multiple others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and more)
  • Key Companies Profiled: Schrödinger, Inc.; Dassault Systèmes SE; Certara, L.P.; Exscientia Limited; Atomwise, Inc.; Cresset, Ltd.; OpenEye Scientific Software, Inc.; Nimbus Therapeutics, LLC; Insilico Medicine, Inc.; BenevolentAI Limited

Key Takeaways for Decision-Makers

  • Advances in artificial intelligence and high-performance computing have transformed virtual screening and predictive modeling workflows, enhancing efficiency and prediction accuracy for both large and niche applications.
  • The convergence of machine learning with traditional chemistry workflows is enabling shorter timelines from lead identification to candidate optimization, fostering more agile R&D cycles for all market participants.
  • Collaborative models, including open innovation platforms and cross-sector partnerships, are gaining prominence, giving rise to more dynamic knowledge sharing and reducing duplication of research efforts.
  • Emergent technologies, such as quantum computing and generative AI, are now complementing established computational methods to address complex molecular interactions and design tasks previously unattainable at scale.
  • Regulatory and regional requirements impact technology preferences, with adoption trends shaped by local data privacy laws, funding mechanisms, and collaborative frameworks among contract research organizations, academia, and industry.
  • Companies prioritizing data standardization, secure cloud-native platforms, and continuous talent development position themselves to extract greater value from computational drug discovery investments.

Tariff Impact: 2025 US Tariffs Affecting R&D and Supply Chain Strategy

Recent US tariffs on core chemical intermediates and laboratory equipment have introduced new operational challenges for drug discovery organizations. These measures have extended procurement timelines, elevated costs, and prompted the evaluation of nearshoring and dual-sourcing strategies to safeguard research continuity. Both industry and academic stakeholders are adapting budgets, revising contracts, and leveraging analytics to model future scenarios. This new landscape underscores the need for robust supply chain resilience and proactive vendor management across the sector.

Methodology & Data Sources

An integrated approach combined secondary research from peer-reviewed publications, patents, and regulatory literature with primary interviews of industry and scientific stakeholders. A benchmarking model mapped vendor offerings to objective performance metrics. Multi-layer validation and expert review underpinned the report’s integrity.

Why This Report Matters

  • Provides deep, actionable insight into key growth areas, allowing leaders to prioritize technology investment and partnership opportunities.
  • Enables effective resource allocation and risk mitigation by detailing changing cost structures, workflow innovation, and compliance requirements.
  • Empowers decision-makers to benchmark their strategies against leading players and emerging disruptors shaping the market’s future direction.

Conclusion

Computer-aided drug discovery is rapidly integrating advanced computation with scientific innovation. Effective leadership demands strategic investment in technology, partnerships, and workforce skills to capitalize on market opportunities. This report delivers the insight necessary for informed action in a dynamic arena.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Application of generative deep learning frameworks for de novo small molecule design and optimization
5.2. Integration of multi-omics data and AI-driven models for precision drug target identification and validation
5.3. Deployment of cloud-native high-performance computing platforms for accelerated virtual screening workflows
5.4. Adoption of quantum computing algorithms to enhance accuracy of molecular docking and binding affinity predictions
5.5. Implementation of explainable artificial intelligence techniques for transparent drug candidate selection and prioritization
5.6. Utilization of autonomous robotic labs integrated with AI for high-throughput synthesis and real-time assay optimization
5.7. Development of digital twin models for in silico pharmacokinetics and toxicity prediction in early drug discovery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Computer-aided Drug Discovery Market, by Molecule Type
8.1. Introduction
8.2. Biologics
8.3. Small Molecules
9. Computer-aided Drug Discovery Market, by Deployment Model
9.1. Introduction
9.2. Cloud-Based
9.3. On-Premises
10. Computer-aided Drug Discovery Market, by Pricing Model
10.1. Introduction
10.2. Pay Per Use
10.3. Perpetual License
10.4. Subscription
11. Computer-aided Drug Discovery Market, by End User
11.1. Introduction
11.2. Academic And Government Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. Computer-aided Drug Discovery Market, by Type
12.1. Introduction
12.2. Services
12.2.1. Consulting
12.2.2. Implementation
12.2.3. Research Outsourcing
12.2.4. Support And Maintenance
12.3. Software
12.3.1. Data Analytics
12.3.2. De Novo Design
12.3.3. Molecular Modeling
12.3.3.1. Ligand Based Design
12.3.3.2. Structure Based Design
12.3.4. QSAR Modeling
12.3.5. Virtual Screening
13. Computer-aided Drug Discovery Market, by Technology
13.1. Introduction
13.2. ADMET Prediction
13.3. Bioinformatics
13.3.1. Functional Genomics
13.3.2. Sequence Analysis
13.4. Chemoinformatics
13.4.1. Library Design
13.4.2. QSAR Modeling
13.4.3. Scaffold Hopping
13.5. De Novo Design
13.6. Molecular Modeling
14. Computer-aided Drug Discovery Market, by Application
14.1. Introduction
14.2. Clinical Trials Support
14.3. Lead Discovery
14.4. Lead Optimization
14.5. Preclinical Development
14.6. Target Identification
15. Americas Computer-aided Drug Discovery Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Computer-aided Drug Discovery Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Computer-aided Drug Discovery Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Schrödinger, Inc.
18.3.2. Dassault Systèmes SE
18.3.3. Certara, L.P.
18.3.4. Exscientia Limited
18.3.5. Atomwise, Inc.
18.3.6. Cresset, Ltd.
18.3.7. OpenEye Scientific Software, Inc.
18.3.8. Nimbus Therapeutics, LLC
18.3.9. Insilico Medicine, Inc.
18.3.10. BenevolentAI Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. COMPUTER-AIDED DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. COMPUTER-AIDED DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. COMPUTER-AIDED DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. COMPUTER-AIDED DRUG DISCOVERY MARKET: RESEARCHAI
FIGURE 30. COMPUTER-AIDED DRUG DISCOVERY MARKET: RESEARCHSTATISTICS
FIGURE 31. COMPUTER-AIDED DRUG DISCOVERY MARKET: RESEARCHCONTACTS
FIGURE 32. COMPUTER-AIDED DRUG DISCOVERY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COMPUTER-AIDED DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLOUD-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ON-PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PAY PER USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PAY PER USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PERPETUAL LICENSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PERPETUAL LICENSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ACADEMIC AND GOVERNMENT INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH OUTSOURCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH OUTSOURCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND BASED DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND BASED DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIBRARY DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIBRARY DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY QSAR MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SCAFFOLD HOPPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SCAFFOLD HOPPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DE NOVO DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 164. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 165. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 166. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 167. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 169. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 174. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 175. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 176. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 177. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 178. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 179. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 184. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 185. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 189. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 192. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 193. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 198. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 199. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 202. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 203. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CHEMOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DEPLOYMENT MODEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY MOLECULAR MODELING, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Computer-aided Drug Discovery market report include:
  • Schrödinger, Inc.
  • Dassault Systèmes SE
  • Certara, L.P.
  • Exscientia Limited
  • Atomwise, Inc.
  • Cresset, Ltd.
  • OpenEye Scientific Software, Inc.
  • Nimbus Therapeutics, LLC
  • Insilico Medicine, Inc.
  • BenevolentAI Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.16 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Computer-Aided Drug Discovery Market Report 2025 - Product Image

Computer-Aided Drug Discovery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Computer-Aided Drug Discovery - Global Strategic Business Report - Product Image

Computer-Aided Drug Discovery - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Computer-Aided Drug Discovery Market - Forecasts from 2025 to 2030 - Product Image

Computer-Aided Drug Discovery Market - Forecasts from 2025 to 2030

  • Report
  • 140 Pages
  • Global
From
2024 Computer-Aided Drug Discovery Market Forecast (2025-2030 Outlook) - Market Opportunities Report - Product Image

2024 Computer-Aided Drug Discovery Market Forecast (2025-2030 Outlook) - Market Opportunities Report

  • Report
  • 70 Pages
  • Global
From
2025 Global Forecast for Computer-Aided Drug Discovery Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Computer-Aided Drug Discovery Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Computer Aided Drug Discovery Market

Computer Aided Drug Discovery (CADD) is a technology-driven approach to drug discovery that uses computer-based methods to identify and develop new drugs. CADD combines the power of computational chemistry, bioinformatics, and machine learning to identify and optimize potential drug candidates. CADD can be used to identify novel drug targets, design and optimize drug molecules, and predict drug-target interactions. CADD can also be used to predict drug metabolism and toxicity, and to identify potential drug-drug interactions. CADD has become an important tool in the drug discovery process, allowing researchers to rapidly identify and develop new drugs. CADD can reduce the time and cost associated with drug discovery, and can help to identify novel drug targets and optimize drug molecules. Some companies in the CADD market include Schrödinger, ChemAxon, Accelrys, and OpenEye Scientific Software. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.